IL-17 A/F heterologous polypeptides and therapeutic uses thereof

Details for Australian Patent Application No. 2004259638 (hide)

Owner Genentech, Inc.

Inventors Lee, James; Arnott, David; Hass, Philip; Wu, Yan; Gurney, Austin

Agent Griffith Hack

Pub. Number AU-B-2004259638

PCT Pub. Number WO2005/010044

Priority 60/486,457 11.07.03 US; 60/485,599 08.07.03 US

Filing date 2 June 2004

Wipo publication date 3 February 2005

Acceptance publication date 3 July 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/24 (2006.01) Mutation or genetic engineering

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/010044 Priority application(s): WO2005/010044

3 July 2008 Application Accepted

  Published as AU-B-2004259638

30 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259640-Replikin peptides and uses thereof

2004259637-Reclosable dispenser